What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Diabetes mellitus
- Disease
Jie Jin Wang mainly focuses on Ophthalmology, Internal medicine, Surgery, Odds ratio and Eye disease.
Jie Jin Wang has researched Ophthalmology in several fields, including Age-related maculopathy and Maculopathy.
Jie Jin Wang combines subjects such as Diabetes mellitus, Retinal and Cardiology with her study of Internal medicine.
Her Surgery study integrates concerns from other disciplines, such as Relative risk, Incidence, Cohort study and Cohort.
Her research investigates the link between Odds ratio and topics such as Confidence interval that cross with problems in Epidemiology, Cycloplegia and El Niño.
Jie Jin Wang has included themes like Visual acuity, Eye examination, Cross-sectional study, Optometry and Pediatrics in her Eye disease study.
Her most cited work include:
- Global Prevalence and Major Risk Factors of Diabetic Retinopathy (2265 citations)
- Prevalence of Age-related Maculopathy in Australia: The Blue Mountains Eye Study (967 citations)
- Risk factors for age-related macular degeneration : Pooled findings from three continents (882 citations)
What are the main themes of her work throughout her whole career to date?
Ophthalmology, Internal medicine, Retinal, Odds ratio and Diabetes mellitus are her primary areas of study.
Her work investigates the relationship between Ophthalmology and topics such as Optometry that intersect with problems in Refractive error and Visual impairment.
Her Internal medicine research includes themes of Endocrinology, Surgery and Cardiology.
Her biological study spans a wide range of topics, including Age-related maculopathy and Cohort study.
Her study looks at the intersection of Retinal and topics like Blood pressure with Body mass index.
Her Odds ratio study deals with Confidence interval intersecting with Epidemiology.
She most often published in these fields:
- Ophthalmology (50.10%)
- Internal medicine (47.04%)
- Retinal (35.40%)
What were the highlights of her more recent work (between 2014-2021)?
- Internal medicine (47.04%)
- Ophthalmology (50.10%)
- Genome-wide association study (15.46%)
In recent papers she was focusing on the following fields of study:
Jie Jin Wang focuses on Internal medicine, Ophthalmology, Genome-wide association study, Genetics and Diabetic retinopathy.
Her Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Endocrinology.
Her study on Ophthalmology is mostly dedicated to connecting different topics, such as Confidence interval.
Her Genome-wide association study research integrates issues from SNP, Allele, Genetic association and Glaucoma.
Diabetic retinopathy is a subfield of Diabetes mellitus that Jie Jin Wang studies.
The study incorporates disciplines such as Cross-sectional study, Body mass index, Surgery and Blood pressure in addition to Diabetes mellitus.
Between 2014 and 2021, her most popular works were:
- A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants (720 citations)
- Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function (296 citations)
- International Photographic Classification and Grading System for Myopic Maculopathy (284 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Diabetes mellitus
- Disease
Her scientific interests lie mostly in Genome-wide association study, Genetics, Internal medicine, Odds ratio and Diabetic retinopathy.
Her Genome-wide association study research incorporates elements of Ophthalmology, Glaucoma, Case-control study and Allele.
The Ophthalmology study combines topics in areas such as Incidence and Cohort.
Her research on Internal medicine often connects related areas such as Endocrinology.
Her studies deal with areas such as Body mass index, Audiology and Risk factor as well as Odds ratio.
She interconnects Retinopathy and Cross-sectional study in the investigation of issues within Diabetic retinopathy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
